# This English translation of the Public Notice has been translated in compliance with the Standard Bilingual Dictionary (March 2006 edition). This is an unofficial translation. Only the original Japanese texts of laws and regulations have legal effect, and the translations are to be used solely as reference material to aid in the understanding of Japanese laws and regulations. The Government of Japan shall not be responsible for the accuracy, reliability or currency of the legislative material provided in this Website, or for any consequence resulting from use of the information in this Website. For all purposes of interpreting and applying law to any legal issue or dispute, users should consult the original Japanese texts published in the Official Gazette.
Notice on the Items of Goods Subject to Import Quotas, the Places of Origin or Places of Shipment of Goods Requiring Permission for Import, and Other Necessary Matters Concerning Import of Goods
(Public Notice of the Ministry of International Trade and Industry of April 30, 1966)
Final revision: Public Notice of the Ministry of Economy, Trade and Industry (September 26, 2006)
Date of Enforcement
- The part pertaining to "Paraguay" in the provision revising III-9 (4)(d): October 16, 2006
- The part pertaining to "Argentina" in the provision revising III-9 (4)(d): November 26, 2006
- The part pertaining to "(2-(2-chlorophenyl)-2-(methylamino) cyclohexanone (Ketamine))"in row 2922.39 of table 1 under I: January 1, 2007
  Pursuant to Article 3, paragraph 1 of the Import Trade Control Order (Cabinet Order No. 414 of 1949), the items of goods subject to import quotas, the places or origin or places of shipment of goods requiring import approval, and other necessary matters concerning import of goods shall be publicized as follows; Public Notice of the Ministry of International Trade and Industry No. 203 of April 1964 (First Notice on the Items of Goods Subject to Import Quotas, the Places of Origin or Places of Shipment of Goods Requiring Permission for Import, and Other Necessary Matters Concerning Import of Goods) shall be abolished, and this Public Notice shall be effective as from May 1, 1966.
I. Items of goods subject to import quotas shall be the items listed in table 1 below that are not liberalized (hereinafter referred to as "Non-Liberalized Items") and the goods listed in table 2.
Table 1 Non-Liberalized Items
|Tariff Table Number|Item|Note|
|0301-99-2|Nishin (Clupea spp.), Tara (Gadus spp., Theragra spp. and Merluccius spp.), Buri (Seriola spp.), Saba (Scomber spp.), Iwashi (Etrumeus spp., Sardinops spp. and Engraulis spp.), Aji (Trachurus spp. and Decapterus spp.) and Samma (Cololabis spp.), live|x|
|03-02|Nishin (Clupea spp.), Tara (Gadus spp., Theragra spp. and Merluccius spp.) and its hard roes, Buri (Seriola spp.), Saba (Scomber spp.), Iwashi (Etrumeus spp,   Sardinops spp. and Engraulis spp.), Aji (Trachurus spp. and Decapterus spp.) and Samma (Cololabis spp.), fresh or chilled|x|
|03-03|Nishin (Clupea spp.), Tara (Gadus spp., Theragra spp. and Merluccius spp.) and its hard roes, Buri (Seriola spp.), Saba (Scomber spp.), Iwashi (Etrumeus spp,   Sardinops spp. and Engraulis spp.), Aji (Trachurus spp.|x|
|03-04|Nishin (Clupea spp.), Tara (Gadus spp., Theragra spp. and Merluccius spp.) and its hard roes, Buri (Seriola spp.), Saba (Scomber spp.), Iwashi (Etrumeus spp,   Sardinops spp. and Engraulis spp.), Aji (Trachurus spp. and Decapterus spp.) and Samma (Cololabis spp.)|x|
|03-05|Nishin (Clupea spp.), Tara (Gadus spp., Therogra spp. and Merluccius spp.), Buri (Seriola spp.), Saba (Scomber spp.), Iwashi (Etrumeus spp., Sardinops spp. and Engraulis spp.), Aji (Trachurus spp. and Decapterus spp.) and Samma (Cololabis spp.), dried, salted or in brine; fish meal fit of those fish; hard roses of Tara (Gadus spp., Theragra spp. and Merluccius spp.), "Niboshi" (small boiled and dried fish for seasoning use)|x|
|03-07|Scallops; adductors of shellfish; cuttle fish and squid other than Mongo ika|x|
|1211-30|Coca leaf||
|1211-40|Poppy straw||
|1211-90-3|Cannabis plant||
|1212-20-1-(1)|Edible seaweeds, fresh or dried, formed into rectangular (including square) papery sheets not more than 430cm2/piece|x|
|1212-20-1-(2)|Edible Porphyra spp. and other seaweeds mixed with Porphyra spp. other than those specified in 1212.20-1-(1) above||
|1212-20-1-(3)|Other edible seaweeds (Genus Enteromorpha, genus Monostroma, genus Kjellmannila and genus Laminaria)|x|
|1301-90|Cannabis resins|x|
|1302-11|Opium|x|
|1302-19-2-(2)|Ertracts or tincture of cannabis and crudecocaine||
|2106-90-2-(2)-E|Food preparations of seaweeds (Porphyra spp., Enteromorpha spp., Monostroma spp., Kjellmaniella spp., and laminaria spp.)|x|
|25-24|Asbestos (Other than that listed in Article 3, paragraph 6 of the Supplementary Provisions of the Cabinet Order on the Partial Revision of the Order for Enforcement of the Industrial Safety and Health Act (Act No. 257 of 2006)).|x|
|26-12|Uranium or thorium ores and concentrates||
|2844-10|Natural uranium and its compounds; alloys (other than ferro-uranium), dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds|x|
|2844-20|Uranium enriched in U 235 and its compounds; plutonium and its compound; alloys (other than ferro-uranium), dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U 235, plutonium or compounds of these products|x|
|2844-30|Uranium depleted in U 235 and its compounds; thorium and its compounds; alloys (other than ferro-uranium), dispersions (including cermets), ceramic products and mixtures containing uranium depleted in U 235, thorium or compounds of these products|x|
|2844-40|Compounds of fissile isotopes or alloys, dispersions (including cermets), ceramic products and mixtures containing these compounds|x|
|2844-50|Spent (irradiated) fuel elements (cartridges) of nuclear reactors|
|2903-29|Hexachlorobuta-1,3-diene (excluding those used for testing and research purposes)|x|
|2903-59|1, 2, 4, 5, 6, 7, 8, 8-Octachloro-2, 3, 3a, 4, 7, 7a-hexahydro-4, 7-methano-1H-indene; 1, 4, 5, 6, 7, 8, 8-heptachloro-3a, 4, 7, 7a-tetrahydro-4, 7-methano-1H-indene; and these mixture of analogous compounds (chlordan or heptachloro) and 1, 2, 3, 4, 10, 10-hexachloro-1, 4, 4a, 5, 8, 8a-hexahydro -exo-1, 4-endo-5, 8-dimethanonaphthalene (aldrin), Polychloro-2,2-dimethyl-3-methylidenebicyclo [2,2,1] heptane (Toxaphene) 1, 1a, 2, 2, 3, 3a, 4, 5, 5a, 5b, 6-dodecachloroacta-hydro-1, 3, 4-metheno-1H-cyclobuta [cd] pentalene (Mirex) (excluding those used for testing and research purposes)|x|
|2903-62|Hexachlorobenzene and 1, 1, 1-trichloro-2, 2-bis (4-chlorophenyl) ethane (DDT) (excluding those used for testing and research purposes)|x|
|2903-69|Polychlorobiphenyl, polychloronaphthalene (more than 3 chlorines) (excluding those used for testing and research purposes)|x|
|2904-20|4-Nitrodiphenyl and its salts|x|
|2906-29|2,2,2-trichloro-1,1- bis (4-chlorophenyl) ethanol (Dicofol) (excluding those used for testing and research purposes)|x|
|2907-19|2,4,6-tri-tert-butylphenol (excluding those used for testing and research purposes)|x|
|2909-19|Bis (chloromethyl) ether|x|
|2910-90|1, 2, 3, 4, 10, 10-Hexachloro-6, 7-epoxy-1, 4, 4a, 5, 6, 7, 8, 8a-octahydro -exo-1, 4-endo-5, 8-dimethanonaphthalene (dieldrin) and 1, 2, 3, 4, 10, 10-Hexachloro-6, 7-epoxy-1, 4, 4a, 5, 6, 7, 8, 8a-octahydro-endo-1, 4-endo-5, 8-dimethanonaphthalene (endrin) (excluding those used for testing and research purposes)|x|
|2914-31|Phenyl propane-2-on (phenylacetone)||
|2918-19|4-hydroxybutyric acid (GHB) and its salts|x|
|2921-45|beta-naphthylamine and its salts|x|
|2921-46|Phenylaminopropane and these salts|x|
|2921-49|4-Aminodiphenyl, N-Ethyl-1-phenylcyclohexylamine (Eticyclidine) and these salts|x|
|2921-51|N, N'-ditolyl-p-phenylenediamine, N-tolyl-N'-xylyl-p-phenylenediamine and N, N'-dixylyl-p-phenylenediamine (excluding those used for testing and research purposes)|x|
|2921-59|Benzidine and its salts|x|
|2922-19|3-Acetoxy-6-dimethylamino-4, 4-diphenylheptane (Acetylmethadol), alpha-3-Acetoxy-6-dimethylamino-4, 4-diphenylheptane (Alphacetylmethadol), beta-3-Acetoxy-6-dimethylkamino-4, 4-diphenylheptane (Betaacetylmethadol), alpha-3-Acetoxy-6-methylamino-4, 4-diphenylheptane (Noracynethadol), 6-Dimethylamino-4, 4-diphenyl-3-heptanol (Dimepheptanol), alpha-6-Dimethylamino-4, 4-diphenyl-3-heptanol (Alphamethadol), beta-6-Dimethylamino-4, 4-diphenyl-3-heptanol (Betamethadol), 4-Dimethylamino-3-methyl-1, 2-diphenyl-2-(propionoxy) butane (Propoxyphene), (2-Dimethylamino) ethyl-1-etoxy-1, 1-diphenylacetate (Dimenoxadol) and these salts|x|
|2922-29|4-Ethyl-2, 5-dimethoxy-alpha-dimethylphenethylamine (DOET), 2, 5-Dimethoxy-4, alpha-dimethylphenethylamine (DOM), 2, 5-Dimethoxy-alpha-methylphenethylamine (DMA), 3, 4, 5-Trimethoxyphenethylamine (Mescaline), 3, 4, 5-Trimethoxy-alpha-methylphenethylamine (TMA), 4-Bromo-2, 5-dimethoxy-alpha-methylphenethylamine (Brolamfetamine), 4-Methoxy-alpha-methylphenetylamine (PMA) and these salts|x|
|2922-31|6-Dimethylamino-4, 4-diphenyl-3-hexanone (Normethadone), 6-Dimethylamino-4, 4-diphenyl-3-heptanone (Methadone) and these salts|x|
|2922-39|6-Dimethylamino-5-methyl-4, 4-diphenyl-3-hexanone (Isomethadone), 2 (methylamino)-1-phenylpropane-1-on, 2-(2-chlorophenyl)-2-(methylamino) cyclohexanone (Ketamine) and these salts|x|
|2922-44|Trans-2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester (Tilidine) and its salts||
|2922-49|7-[(10, 11-dihydro-5H-dibenzo [a,d] cyolohepten-5-yl) amino] heptanacid (amineptine) and its Salts|x|
|2924-29|N-"(2-methylphenethylamino) propyl" propionanilide (Diampromide) and its salts|x|
|2926-30|4-Cyano-2-dimethylamino-4,4-diphenylbutane (Methadone Intermediate) and its salts|x|
|2930-90|alpha-methyl-4-methylthiophenethyl amine (4-MTA), 2,5-dimethoxy-4-(propylthio) phenethylamine and its salts|x|
|29-31|Bis (tributyltin) =Oxido excluding those used for testing and research purposes|x|
|2932-95|6a, 7, 8, 9-tetrahydro-6, 6, 9 -trimethyl-3-pentyl-6H-dibenzo [b, d] pyran-1-ol (delta-10-tetrahydrocannabinol), 6a, 7, 8, 10a-tetrahydro-6, 6, 9-trimethyl-3-penthyl-6H-dibenzo[b, d]pyran-1-ol (delta-9-tetrahydrocannabinol) (obtained by chemical reactions other than decomposition (except those needed to purify 6a, 7, 8, 10a-tetrahydro- 6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b, d] pyran-1-ol including cannabis plants prescribed by Article 1 of the Cannabis Control Act (Act No. 124 of 1948) (hereinafter referred to as "Cannabis plants") and their products), 6a, 7, 10, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b, d] pyran-1-ol (obtained by chemical reactions other than decomposition (except those needed to purify 6a, 7, 8, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b, d] pyran-1-ol including Cannabis plants and their products)), 6a, 9, 10, 10a-tetrahydro-6, 6, 9-trymethyl-3-pentyl-6H-dibenzo [b, d] pyran-1-ol (delta-7- tetrahydrocannabinol), 7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo[b, d]pyran-1-ol (delta-6a(10a)-tetrahydrocannabinol), 8, 9, 10, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b, d] pyran-1-ol (delta-6a(7)- tetrahydrocannabinol), 6a, 7, 8, 9, 10, 10a-hexahydro-6, 6-dimethyl-9-methylene-3-pentyl-6H-dibenzo [b, d] pyran-1-ol (delta-9(11)-tetrahydrocannabinol) and their salts:|x|
|2932-99|N-ethyl-alpha-methyl-3,4- (methylenedioxy) phenethylamine (N-ethyl MDA), 3-(1,2-dimethylhepthyl) -7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran-1-ol (DMHP), N-alpha-dimethyl-3,4- (methylenedioxy) phenethylamine (MDMA), 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran-1-ol (Parahexyl), alpha-methyl-3,4-(methylenedioxy) phenetylamine (MDA), N- (alpha-methyl-3,4- (methylenedioxy) phenethyl) hydroxylamine (N-hydroxy MDA), 3-methoxy-alpha-ethyl-3,4- (methylenedioxy) -phenethylamine (MMDA), N-methyl-alpha-ethyl-3,4- (methylenedioxy) phenethylamine (MBDB) and these salts|x|
|2933-33|N- [1- [2- (4-ethyl-5-oxo-2-tetrazoline-1-yl) ethyl] 4- (methoxymetyl) -4-pyperidyl] propyonanilide (Alfentanil), Ethyl1- [2- (4-aminophenyl) ethyl] -4-phenylpiperidine-4-carboxylate (Anileridine), Ethyl 1- (3-cyano-3,3-diphenylpropyl) -4-phenylpiperidine-4-carboxylate (Diphenoxylate), 4-cyano-1-methyl-4-phenylpiperidine (Pethidine-Intermediate-A), 4, 4-diphenyl-6-piperidino-3-heptanone (Dipipanone), 1, 2, 5-trimethyl-4-phenyl-4- (propionyloxy) piperidine (Trimeperidine), Ethyl 1- (3-hydroxy-3-phenylpropyl) -4-phenylpiperidine-4-carboxylate (Phenoperidine), 4- (3-hydroxyphenyl) -1-methyl-4-piperidylethylketone (Ketobemidone), 1- (3-cyano-3, 3-diphenylpropyl) -4- (2-oxo-3-propionyl-1-benzimidazolinyl) piperidine (Bezitramide), 1- (3-cyano-3,3-diphenylpropyl) -4- (1-piperizyno) piperidine-4-carboxyamide (Piritramide), 1- (3-cyano-3,3-diphenylpropyl) -4-phenylpiperidine-4-carbonic acid (Difenoxin), 1- (1-phenylcyclohexyl) piperidine (Phencyclidine), N- (1-phenethyl-4-piperidyl) propionanilide Fentanyl), N- [1-methyl-2- (piperidinoethyl)] -N-2-pyridylpropionamide (Propiram), Methyl 2-phenyl-2- (2-piperidyl) -acetate (Methylphenidate), Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate and these salts|x|
|2933-39|3-allyl-1-methyl-4-phenyl-4- (propionyloxy) piperidine (Allylprodine), alpha-3-ethyl-1-methyl-4-phenyl-4- (propionyloxy) piperidine (Alphameprodine), beta-3-ethyl-1-methyl-4-phenyl-4- (propionyloxy) piperidine (Betameprodine), alpha-1, 3-dimethyl-4-phenyl-4- (propionyloxy) piperidine (Alphaprodine), beta-1,3-dimethyl-4-phenyl-4- (propionyloxy) piperidine (Betaprodine), Ethyl 1- [2- (2-hydroxyethoxy) ethyl] -4-phenylpiperidine-4-carboxylate (Ethoxeridine) Ethyl 4- (3-Hydroxyphenyl) 1-Methylpiperidine-4-carboxylate (Hydroxypethidine), Ethyl 4-phenylpiperidine-4-carboxylate(Pethidine-Intermediate-B), Ethyl 4-phenyl-1- (3-phenylaminopropyl) piperidine-4-carboxylate (Piminodine), Ethyl 1- [2- (benzyloxy) ethyl] -4-phenylpiperidine-4-carboxylate (Benzethidine), N- (1-methyl-2-piperidinoethyl) propionanilide (Phenampromide), 1-methyl-4-phenylpiperidine-4-carboxylate (other than Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate), 4, 4-diphenyl-6-piperidino-3-hexanone (Norpipanone), N-[1-(-hydroxyphenetyl) -4-piperidyl] propionanilide (-hydroxyfentanyl), N- [1- (-hydroxyphenethyl) -3-methyl-4-piperidyl] propionanilide(-hydroxy-3-methylphentanyl), 1-phenethyl-4-phenyl-4-acetoxypiperidine (PEPAP), 4-fluoro-N- (1-phenylethyl-4-piperidyl) propionanilide (Parafluorofentanyl), 1-methyl-4-phenylpiperidine-4-carboric acid (Pethidine-Intermediate-C), N- (3-methyl-1-phenethyl-4-piperidyl) propionanilide (3-methylfentanyl), 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), N- [1- (a-methylphenethyl) -4-piperidyl] acetoanilide (Acetyl-a-methylfentanyl), N- [1- (a-methylphenethyl) -4-piperidyl] propionanilide (a-methylfentanyl), Methyl 1- (2-metoxycarbonylethyl) -4- (phenylpropionylamino) piperidine-4-carboxylate (Remifentanil), 1, 2, 3, 4, 5, 6-hexahydro-8-hydroxy-6, 11-dimethyl-3-phenethyl-2, 6-methano-3-benzazocin (Phenazocine), 1, 2, 3, 4, 5, 6-hexahydro-8-hydroxy-3, 6, 11-trimetyl-2,6-methano-3-benzazocin (Metazocine) and these salts|x|
|2933-41|3-hydroxy-N-methylmorphinan (excluding of dextrotatory) and this salts||
|2933-49|3-hydroxy-N-pheracylmorphinan (excluding of dextrotatory), 3-hydroxy-N-phenethylmorphinan (Phenomorphan), 3, 4-dimethoxy-1, 7-methylmorphinan-6beta, 14-diol (Drotebanol) and these salts|x|
|2933-53|5-Allyl-5- (1-methylbutyl) barbituric acid (Secobarbital) and its salts|x|
|2933-55|alpha- (alpha-methoxybenzyl) -4- (s-methoxyphenethyl) - 1-pyperadinethanol (Dipeprol), 3- (2-Chlorophenyl) -2-methyl-4 (3H) -quinazolinone (mecloqualone),2-methyl-3- (2-tolyl) -4 (3H) -quinazolinone (Methaqualone) and these salts|x|
|2933-59|1- (3-triflnoromethylphenyl) piperazine, 1-benzylpiperazine and these Salts|x|
|2933-99|2- (4-chlorobenzyl) -1- (diethylamino) ethyl-5-nitrobenzimidazole (Clonitazene), 1- (diethylamino) ethyl-2- (4-ethoxybenzyl) -5-nitrobenzimidazole (Etonitazene), 1, 3-dimethyl-4-phenyl-4- (propionyloxy) azacycloheptane (Proheptazine), 3- (2-aminobutyl) indole (Etryptamine), 3- [2- (diethylamino) ethyl]indole (DET), 3- [2- (dimethylamino) ethyl]indole (DMT), 3- [(2-dimethylamino) ethyl] -indole-4-yl phosphate (Psilocybin), 3- [2- (dimethylamino) ethyl] -indole-4-ol (Psilocin), 1- (1-phenylcyclohexyl) pyrrolidine(Rolicyclidine), 3, 7-dihydro-1, 3-dimethyl-7 [2- [(alpha-methylphenethyl) amino]ethyl]-1H-purine-2, 6-dione (Fenethylline), 3- [2- (diisopropylamino) ethyl] -5-methoxyindole(5-Meo-DIPT), 3- (2-aminopropyl) - indole (AMT) and these salts|x|
|2934-91|N- [4- (methoxymethyl) -1- (2- (2-thyenyl) ethyl) -4-piperidyl] -propionanilide (Sufentanil), 3-methyl-2-phenylmorpholine (Phenmetrazine) andthese salts:|x|
|2934-99|3- (N-ethyl-N-methylamino) -1, 1-di- (2-thienyl) -1-butene (Ethylmethylthiambutene), 3-diethylamino-1, 1-di- (2-thienyl) -1-butene (Diethylthiambutene), 3-dimethylamino-1, 1-di- (2-thienyl) -1-butene (dimethylthiambutene), Ethyl 4-phenyl-1- [2- (tetrahydrofurfuryloxy) ethyl] piperidine-4-carboxylate (Furethidine), [(3-methyl-4-morpholino-2, 2-diphenyl) buthylyl] pyrroridine, 2-methyl-3-morpholino-1, 1-diphenyl (Moramide intermediates), Ethyl 1- (2-morphorinoethyl) -4-phenylpiperidine-4-carboxylate (Morpheridine), 6-morpholino-4, 4-diphenyl-3-heptanone (Phenadoxone), Ethyl 4-morphorino-2, 2-diphenylbutylate (Dioxaphetyl butyrate), cis-2-amino-4-methyl-5-phenyl-2-oxazoline (4-methylaminorex), N- [1- [2- (2-thienyl) ethyl] -4-piperidyl] propionanilide (Thiofentanyl), 1- [1- (2-thienyl) cyclohexyl]piperidine (Tenocyclidine), N- [1- [1-methyl-2- (2-thienyl) ethyl] -4-piperidyl] propionanilide (a-methylthiofentanyl), N- [3-methyl-1- [2- (2-thienyl) ethyl] -4-piperidyl] propionanilide (3-methylthiofentanyl) and these salts:|x|
|2939-11|The following substances and their salts:|x|
||(a) Codeine and ethylmorphine||
||(b) Diacetylmorphine (Heroin)||
||(c) Dihydrocodeinone (Hydrocodone) and its ester||
||(d) Dihydrocodein||
||(e) Dihydrohydroxycodeinone (Oxycodone)||
||(f) Dihydrohydroxymorphinone (Oxymorphone)||
||(g) Dihydromorphinone (Hydromorphone)||
||(h) Thebaine||
||(i) Morphine||
||(j) 7, 8-dihydro-7alpha- (1 (R)-hydroxy-1-methylbuthyl) -6-o-methyl-6, 14-endo-ethenomorphine (Etorphine)||
|2939-19|The following substances and their salts:|x|
||(a) N-allylnormorphine (Nalorphine) and its ester||
||(b) Dihydrodeoxymorphine (Desomorphine) and its ester||
||(c) Dihydromorphine and its ester||
||(d) 6-nicotinylcodeine (Nicocodine)||
||(e) Normorphine (Demethylmorphine) and its ether||
||(f) 14-hydroxydihydromorphine (Hydromorphinol)||
||(g) 6-methyldihydromorphine (Methyldihydromorphine)||
||(h) Methyldihydromorphinone (Metopon)||
||(i) 6-methyl-delta-6-deoxymorphine (Methyldesorphine)||
||(j) Morphine-N-oxide and other pentavalent nitrogen morphine derivatives||
||(k) 3-O-acetyl-7, 8-dihydro-7alpha- [1(R) -hydroxy-1-methylbutyl] -6-O-methyl-6,    14-endo-ethenomorphine (Acetorphine)||
||(l) Dihydrocodeinone-6-carboxymethyloxime (Codoxime)||
||(m) 7, 8-dihydro-7-alpha- [1-R-hydroxy-1-methylbutyl] -6, 14-endo-ethanotetrahydrooripavine||
||(n) Ether of morphine (Other than codeine and ethylmorphine)||
||(o) Ester of morphine (Other than diacetylmorphine (Heroin) )||
||(p) Ester of dihydrocodeinone (Hydrocodeine)||
||(q) Ester of dihydrocodeine||
||(r) Ester of dihydrohydrocodeinone (Oxycodone)||
||(s) Ester of dihydromorphinone (Hydromorphinone)||
|2939-41|1-phenyl-2-methylaminopropanol-1 (Ephedrine) and its salts||
|2939-42|1-phenyl-2-methylaminopropanol-1 (Pseudoephedrine) and its salts||
|2939-49|1-phenyl-2-dimethylaminopropanol-1, erythro-2-amino-1-phenylpropane-1-ol (norephedrine) and these salts|x|
|2939-69|Lysergic acid diethylamide (Lysergide) and its salts|x|
|2939-91|Ecgonine, Cocaine, phenyl methylaminopropane and other esters and these salts|x|
|2939-99|2- Aminopropiophenone phenyl methylaminopropane, 1 - phenyl - 1 -chloro - 2 - methylaminopropane, 1 - Phenyl - 1 - chloro - 2 - dimethylaminopropane, 1 - Phenyl - 2 di - methylaminopropane and these salts|x|
|3002-10|Antisera for human (excluding those for experimental use, and investigational reagents for antigen-antibody reaction|x|
|3002-20|Vaccines for human medicine (excluding those for experimental use and yellow fever vaccine)|x|
|3002-30|Vaccine against foot and mouth disease (excluding those for experimental use)|x|
|30-03|Preparations containing goods of subheadings 1211.30, 2918.19, 2921.49, 2922.19 - 2930.90 and 2932.95-2939.99 (other than 4-Aminodiphenyl or its salts), except those shown below:|x|
||(a) Preparations containing less than 1% by the weight of codeine, dihydorocodeine or these salts, but not containing goods other than articles (except Codeine, Dihydorocodeine, 4-Aminodiphenyl or these salts) specified in 1, 2, 3, 4 or 5.||
||(b) Plants (including its parts) other than those for materials of narcotic drugs||
||(c) Goods containing less than 10% by the weight of 1-Phenyl-2-methylaminopropanol-1||
||(d) Goods containing less than 10% by the weight of 1-Phenyl-2-dimethylaminopropanol-1||
||(e) Goods containing less that 50% by the weight of erythro-2-amino-1-phenylpropane-1-ol||
|30-03|Preparations containing goods of subheadings 1211.30, 2918.19, 2921.49, 2922.19 - 2930.90 and 2932.95-2939.99 (other than 4-Aminodiphenyl or its salts), except those shown below:|x|
||(a) Preparations containing less than 1% by the weight of codeine, dihydorocodeine or these salts, but not containing goods other than articles (except Codeine, Dihydorocodeine, 4-Aminodiphenyl or these salts) specified in 1, 2, 3, 4 or 5.||
||(b) Plants (including its parts) other than those for materials of narcotic drugs||
||(c) Goods containing less than 10% by the weight of 1-Phenyl-2-methylaminopropanol-1||
||(d) Goods containing less than 10% by the weight of 1-Phenyl-2-dimethylaminopropanol-1||
||(e) Goods containing less that 50% by the weight of erythro-2-amino-1-phenylpropane-1-ol||
|3404-90|Polychlorobiphenyl and polychloro-naphthalene excluding those used for testing and research purposes|x|
|3506-91|Rubber adhesives, containing more than 5% of benzene by volume of solvent (including diluent) used therein|x|
|36-01|Propellent powders||
|36-02|Prepared explosives, other than propellent powders||
|36-03|Safety fuses; detonating fuses; percussions or detonating caps; igniters (except as follows); electric detonators|x|
||(a) Igniters, containing less than 0.xx g of black propellant powders, electric ignition system||
||(b) Igniters, incorporated into the gas-generator for automobile airbag, listed in (1) to (6) as follows:||
|| (1) Igniters of which the weight is not more than 0.26 g of propellant powders (perchlorate); or a weight not more than 0.09 g and a weight not more than 0.025 g of prepared explosives. If two ignition parts (parts of igniter, filled with igniter powder) are used, the weight of propellant powders in each part is not more than 0.26 g||
|| (2) Igniters which have an electric ignition system, igniting external gas generant||
|| (3) Igniters which cannot refill propellant powders/prepared explosives and cannot be reused||
|| (4) Igniters of which the casing has rust-resistance||
|| (5) Igniters in which internal propellant powders/prepared explosives cannot be removed easily; or||
|| (6) Igniters of which, if two ignition parts are used, each part meets requirements (1) to (5) above, and ignition of one part cannot cause ignition of other parts.||
||(c) Igniters, incorporated into the gas-generator for automobile seat belt pretensioners, including the L-type gas generator, for automobile restraints, or for an automobile engine hood pop-up system to reduce impact to pedestrians, listed in (1) to (6) as follows:||
|| (1) Igniters of which the weight is not more than 0.26 g of propellant powders (perchlorate); or a weight not more than 0.09 g and a weight not more than 0.025 g of prepared explosives. If the igniter is used for automobile restraints, the weight of propellant powders in each part is not more than 0.25 g||
|| (2) Igniters which have an electric ignition system, igniting external gas generant||
|| (3) Igniters which cannot refill propellant powders/prepared explosives and cannot be reused||
|| (4) Igniters of which the casing has rust-resistance; or||
|| (5) Igniters in which internal propellant powders/prepared explosives cannot be removed easily||
|36-05|Yellow phosphorus matches|x|
|38-22|Preparations and other products containing more than 1% by weight of 4-nitrodiphenyl or its salts, bis (chloromethyl) ether, benzidine or its salts, 4-aminodiphenyl or its salts or of beta-naphthylamine or its salts|x|
|3924-90|Preparations and other products containing more than 1% by weight of 4-nitrodiphenyl or its salts, bis (chloromethyl) ether, benzidine or its salts, 4-aminodiphenyl or its salts, beta-naphthylamine or its salts, polychlorinated biphenyl or its salts or of polychlorinated naphthalenes or its salts|x|
|4005-20|Rubber adhesives, containing more than 5% of benzene by volume of solvent (including diluent) used therein||
|4016-99|Rubber adhesives, containing more than 5% of benzene by volume of solvent (including diluent) used therin|x|
|8109-90|Tubes of zirconium|x|
|8401-10|Nuclear reactors||
|8401-30|Fuel elements (cartridges), non-irradiated||
|8401-40|Parts of nuclear reactors||
|84-11|Engines and motors for military aircraft, other than parts|x|
|8412-10|Engines and motors for military aircraft|x|
|8412-39|Engines and motors for military aircraft|x|
|8412-80|Engines and motors for military aircraft|x|
|87-10|Tanks and other armored fighting vehicles, motorized, whether or not fitted with weapons, and parts of such vehicles||
|88-02|Military aircraft other than those of subheading 8802.60|x|
|89-06|Warships|x|
|9030-10|Instruments and apparatus containing nuclear fuel materials, for measuring or detecting ionizing radiations|x|
|9030-90|Parts and accessories containing nuclear fuel materials, of instruments and apparatus for measuring or detecting ionizing radiations|x|
|93-01|Military weapons||
|93-02|Revolvers and pistols||
|93-03|Other firearms and similar devices which operate by the firing of an explosive charge||
|93-04|Other arms||
|93-05|Parts and accessories of articles of headings 93.01 to 93.04, excluding those of plastics, rubber, leather, composition leather or textile materials specified in subheading 9305.99|x|
|93-06|Bombs, grenades, torpedoes, mines, missiles, and similar munitions of war and parts thereof; cartridges and other ammunition and projectiles and parts thereof, including shot and cartridge wads||
|93-07|Swords, cutlasses, bayonets, lances and similar arms and parts thereof and scabbards and sheaths therefor||
Table 2 Products Containing CITES Fauna and Flora and Derivatives Thereof, Controlled Substances under the Montreal Protocol and the Stockholm Convention on Persistent Organic Pollutants, and Asbestos
1 Animals belonging to the species included in Appendix I of the Convention on International Trade in Endangered Species of Wild Fauna and Flora; hereinafter referred to as "CITES") (excluding the sperm whale, beaked whale, minke whale, sei whale, Bryde's whale, rorquals, and Irrawaddy dolphin) or plants belonging to the species included in the same Appendix (these animals and plants shall hereinafter be referred to as "CITES Fauna and Flora"), and parts thereof
2 Eggs, seeds, bulbs, fruits (including pericarp), stuffing or processed products (hereinafter referred to as "Derivatives"), which pertain to the CITES Fauna and Flora
3 Substances included in Group I in Annex A of the Montreal Protocol on Substances that Deplete the Ozone Layer (hereinafter referred to as the "Montreal Protocol") (excluding those imported by persons who are required to obtain import approval under Article 4, paragraph 1, item 2 of the Import Trade Control Order (said approval and said order shall hereinafter be referred to as "Item 2 Approval" and the "Order," respectively), those used as raw materials in the manufacturing process of other substances, and those used for test and research or analysis), substances included in Group II of Annex A of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry and those used as raw materials in the manufacturing process of other substances), substances listed in Annex B of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry, those used as raw materials in the manufacturing process of other substances, and those used for test and research or analysis), substances included in Group I of Annex C of the same Protocol (excluding those used as raw materials in the manufacturing process of other substances), substances included in Group II of Annex C of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry and those used as raw materials in the manufacturing process of other substances), substances included in Group III of Annex C of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry and those used as raw materials in the manufacturing process of other substances), and substances listed in Annex E of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry, those used as raw materials in the manufacturing process of other substances, and those used for quarantine upon import and export of goods)
4 Products specified by a Cabinet Order under Article 13, paragraph 1 of the Act on the Evaluation of Chemical Substances and Regulation of Their Manufacturing (Act No. 117 of 1973) which contain Class I Specified Chemical Substances (limited to those containing chemicals listed in Annex A or Annex B of the Stockholm Convention on Persistent Organic Pollutants)
5 Preparations and other substances containing substances listed in Article 16, paragraph 1, item 4 of the Order for Enforcement of the Industrial Safety and Health Act (Cabinet Order No. 318 of August 19, 1972) over 0.1% by weight (excluding those listed in the items of Article 3 of the Supplementary Provisions of the Cabinet Order for Partial Revision of the Order for Enforcement of the Industrial Safety and Health Act (Cabinet Order No. 257 of 2006))
II. Item 2 Approval shall be obtained from the Minister of Economy, Trade and Industry in order to import the goods listed in table 1 and table 2 below.
Table 1 Goods listed in the right column of the table below originating in or shipped from the regions listed in the left column
|Area|Freight|
||Item No.|Tariff table No.|Freight Name|
|Countries or regions other than Countries Listed in III-9|0106-12|Whale and its preparation, shipped from outside Japanese waters, but not that loaded in foreign port; except those shown in Table 2 of I. (hereinafter the same applies)|
|||0208-40||
|||0210-92||
|||1504-30||
|||1521-90||
|||16-01||
|||1602-10||
|(1)||1602-20||
|||1602-31||
|||1602-39||
|||1602-49||
|||1602-50||
|||1602-90||
|||2301-10||
|||2309-10||
|||2309-90||
|Countries or regions excluding those listed in III.9(1)(Limited to when the country is the place of origin)||0302-35|Bluefin tunas, fresh or chilled, bred in the Atlantic Ocean or Mediterranean Sea|
|||0302-70-2||
|||0304-10-1-(2)||
|||0304-10-2-(2)||
|||0304-90-2||
|Countries or regions excluding those listed in III.9(1)(Limited to when the country is the place of origin)||0302-36|Southern bluefin tunas, fresh or chilled|
|||0302-70-2||
|||0304-10-1-(2)||
|||0304-10-2-(2)||
|||0304-90-2||
|Bolivia and Georgia (it limits when particular country is designated as the place of origin.)||0301-10-2|Bigeye tuna and its preparations|
|||0301-99-1||
|||0301-99-2-(2)||
|||0302-34||
|||0302-70-2||
|||0303-44||
|||0303-80-3||
|||0304-10-1-(2)||
|||0304-10-2-(2)||
|||0304-20-2||
|||0304-90-2||
|||0305-10||
|||0305-20-4||
|||0305-30-2||
|||0305-49||
|||0305-59-2||
|||0305-69-2||
|||1604-14||
|||1604-20-1-(2)||
|||1604-20-2||
|||2301-20||
|||2309-10||
|||2309-90||
|China, North Korea and Taiwan||0301-91-2|Bigeye tuna and its preparations|
|||0301-99-2||
|||0302-11||
|||0302-12||
|||0302-19||
|||0302-70||
|||0303-11||
|||0303-19||
|||0303-21||
|||0303-22||
|||0303-29||
|||0303-80||
|||03-04||
|||0305-10||
|||0305-20||
|||0305-30||
|||0305-41||
|||0305-49||
|||0305-59||
|||0305-69||
|||1604-11||
|||1604-19||
|||1604-20||
|Outside of Japanese waters but not that loadedin a foreign port, shipped therein; in case of those loaded in a foreign port and imported by fishing vessels from Japan; except those reshipped from other than ships/boats from Japan|1|0106-12|Marine animals and their preparations|
|||0208-40||
|||0210-92||
|||1504-30||
|||1521-90||
|||16-01||
|||1602-10||
|||1602-20||
|||1602-31||
|||1602-39||
|||1602-49||
|||1602-50||
|||1602-90||
|||2301-10||
|||23-09||
||2|0208-40|Fish, crustaceans and other aquatic animals and their preparations|
|||0210-92||
|||03-01||
|||03-02||
|||03-03||
|||03-04||
|||03-05||
|||03-06||
|||03-07||
|||1504-10||
|||1504-20||
|||15-06||
|||16-04||
|||16-05||
|||2106-90||
|||2301-20||
|||23-09||
||3|05-04|Products of animal origin, of marine animals, fish, crustaceans and molluscs|
|||05-06||
|||05-07||
|||05-08||
|||05-09||
|||0511-91||
|||0511-99||
||4|1212-20|Seaweed and its preparation|
|||2106-90||
|Iraq||97-01|Cultural property unlawfully acquired in Iraq on and after August 6, 1990 other than specified foreign cultural property listed in 3 6-(4)|
|||97-02||
|||97-03||
|||97-04||
|||97-05||
|||97-06||
|Liberia (limited to the case of as the place of origin)||44-01|Logs and articles of wood|
|||44-02||
|||44-03||
|||44-04||
|||44-05||
|||44-06||
|||44-07||
|||44-08||
|||44-09||
|||44-10||
|||44-11||
|||44-12||
|||44-13||
|||44-14||
|||44-15||
|||44-16||
|||44-17||
|||44-18||
|||44-19||
|||44-20||
|||44-21||
|Liberia and Republic of Cote d'Ivoire||7102-10|Diamonds|
|||7102-21||
|||7102-31||
|Countries and regions other than Liberia and Republic of Cote d'Ivoire||7102-10|Diamonds other than those imported through the procedures of 3 8-(10)|
|||7102-21||
|||7102-31||
Table 2 CITES Fauna and Flora and Derivatives Thereof, Substances Prescribed in the Annexes of the Montreal Protocol, and Specified Chemicals and Class I Designated Chemicals Prescribed in the Act on Prohibition of Chemical Weapons and Control, etc. of Specific Chemicals, etc.
1 Animals belonging to the species listed in CITES Appendix II which originate in or are shipped from countries or regions other than the countries and regions listed in III-9(3)(a) and (b) (excluding those listed in the row "Countries or regions other than Countries Listed in III-9(1)" in table 1 and all species belonging to Rhincodon, Cetorhinus, Carcharodon, and Hippocampus) and plants belonging to the species listed in the same Appendix which originate in or are shipped from said countries or regions, and parts and Derivatives thereof (in the case of parts and Derivatives of plants, limited to those identified based on Appendix II), and animals and plants belonging to the species listed in CITES Appendix III which originate in the countries listed in CITES Appendix III and parts and Derivatives thereof identified based on Appendix III
2 Substances listed in Annex A of the Montreal Protocol and products listed in Annex D of the same Protocol which originate in or are shipped from the countries or regions other than the countries and regions listed in III-9(4)(a), substances listed in Annex B of the same Protocol which originate in or are shipped from the countries or regions other than the countries and regions listed in III-9(4)(b), substances included in Group II of Annex C of the same Protocol and substances listed in Annex E of the same Protocol which originate in or are shipped from countries or regions other than the countries and regions listed in III-9(4)(c), substances included in Group III of Annex C of the same Protocol which originate in or are shipped from countries or regions other than the countries and regions listed in III-9(4)(d), and substances included in Group I of Annex C of the same Protocol which originate in or are shipped from countries and regions other the countries and regions listed in III-9(4)(e)
3 Specified Hazardous Waste, etc, prescribed in Article 2, paragraph 1 of the Act on the Control of Import, Export, etc. of Specified Hazardous Wastes and Other Wastes (Act No. 108 of 1992) and waste prescribed in Article 2, paragraph 1 of the Waste Disposal and Public Cleaning Act (Act No. 137 of 1970) which are shipped from any countries or regions (excluding waste generated from the navigation of vessels and aircrafts listed in item 2 of paragraph 4 of the same Article and waste carried by persons who enter Japan)
4 Specific Chemicals prescribed in Article 2, paragraph 3 of the Act on Prohibition of Chemical Weapons and Control, etc. of Specific Chemicals, etc. (Act No. 65 of 1995; hereinafter referred to as the "Chemical Weapons Prohibition Act") which are shipped from any countries or regions
5 Class I Designated Chemicals prescribed in Article 2, paragraph 5 of the Chemical Weapons Prohibition Act and chemicals containing Class I Designated Chemicals (with respect to Class I Designated Chemicals listed in column 3 of row 2 of the appended table of the Order for Enforcement of the Act on Prohibition of Chemical Weapons and Control, etc. of Specific Chemicals (Cabinet Order No. 192 of 1995), excluding those that contain said Class I Designated Chemicals at not more than 1% of the total weight; with respect to Class I Designated Chemicals listed in column 4 of the same row, excluding those that contain said Class I Designated Chemicals at not more than 10% of the total weight and those packaged for retail sales to be used for private purposes (including those in bottles, cans, tubes or other containers), which are shipped from countries or regions other than the countries and regions listed in III-9(5)
III. Other matters concerning import of goods shall be provided for as follows: import approval under Article 4, paragraph 1 of the Order shall not be required in the cases: where a person who intends to import goods listed in 6 has obtained confirmation from the minister designated for the respective categories of goods set forth in 6(1) to (4); where a person who intends to import goods listed in 7 has obtained confirmation from the Minister of Economy, Trade and Industry; and where a person who intends to import goods listed in 8 has submitted the documents specified for the respective categories of goods set forth in 8(1) to (12).
1 The term "Customs Tariff Schedule" as used in this Notice shall mean the Custom Tariff Schedules appended to the Customs Tariff Act (Act No. 54 of 1910); the term "Customs Tariff Schedule Number, etc." shall mean the numbers given to the Customs Tariff Schedules or the numbers or signs given as the subdivision codes corresponding to the subdivisions of the items in the description column in appended table 1 of the Act on Interim Measures Concerning Customs (Act No. 36 of 1961)
2 The scope of Non-Liberalized Items and goods listed in table 1 under II shall be determined within the range prescribed in the respective subheadings in the Customs Tariff Schedules and in accordance with the notes attached to the respective subheadings and Sections or Chapters.
3 Non-Liberalized Items which are marked with 'x' in the note column of table 1 under I mean that some of the items identified based on the Customs Tariff Schedule Number, etc. are Non-Liberalized Items.
4 With respect to Non-Liberalized Items and goods listed in table 2 under I, the due date for application for import quotas, the authority to which a written application should be submitted, the documents to be attached to the application and other necessary matters shall be specified separately.
5 (1) With respect to Specified Hazardous Waste prescribed in Article 2, paragraph 1 of the Act on the Control of Import, Export, etc. of Specified Hazardous Wastes and Other Wastes and waste prescribed in Article 2, paragraph 1 of the Waste Disposal and Public Cleaning Act, which are listed in table 2 under II, the due date for application for Item 2 Approval, the authority to which a written application should be submitted, the documents to be attached to the application and other necessary matters shall be specified separately.
  (2) With respect to Specific Chemicals prescribed in Article 2, paragraph 3 of the Chemical Weapons Prohibition Act which are listed in table 2 under I, the due date for application, the authority to which a written application should be submitted, the documents to be attached to the application and other necessary matters shall be specified separately.
6 (1) A person who intends to import vaccine of microbial origin for experimental use (limited to those for human medicine and vaccine against foot and mouth disease; the same shall apply hereinafter) shall make confirmation with the Minister of Health, Labour and Welfare or the Minister of Agriculture, Forestry and Fisheries that said vaccine of microbial origin to be imported is for experimental use.
  (2) A person who intends to import antisera for humans for experimental use shall obtain confirmation from the Minister of Health, Labour and Welfare that said antisera for humans to be imported is for experimental use.
(3) A person who intends to import uranium catalysts shall make confirmation with the Minister of Education, Culture, Sports, Science and Technology that said uranium catalysts are imported to be used by a person who has obtained permission from the Minister of Education, Culture, Sports, Science and Technology under Article 52, paragraph 1 or Article 55, paragraph 1 of the Act on the Regulations of Nuclear Material Substances, Nuclear Fuel Substances and Nuclear Reactors (Act No. 166 of 1957).
(4) A person who intends to import Specified Foreign Cultural Property designated under Article 3, paragraph 2 of the Act on the Control, etc. of Illicit Import and Export of Cultural Property, etc. (Act No. 81 of 2002) shall obtain confirmation from the Minister of Education, Culture, Sports, Science and Technology that said cultural property to be imported is not required to be returned to the country in the case where notification under Article 3, paragraph 1 of the same Act has been made to the foreign minister of said country.
7 (1) A person who intends to import chlordane, aldrin, hexachlorobenzene, DDT, polychlorinated biphenyls, polychloronaphthalene, 2,4,6-tri-tert-butylphenol, dieldrin, endrin, N, N'-ditolyl-p-phenylenediamine, N-tolyl-N'-xylyl-p-phenylenediamine, N, N'-dixylyl-p-phenylenediamine, bis(tributyltin) =Oxido, toxaphene, mirex, hexachlorobuta-1,3-diene, or dicofol for testing and research purposes shall make confirmation with the Minister of Economy, Trade and Industry that said chlordane, aldrin, hexachlorobenzene, DDT, polychlorinated biphenyls, polychloronaphthalene, 2,4,6-tri-tert-butylphenol, dieldrin, endrin, N, N'-ditolyl-p-phenylenediamine, N-tolyl-N'-xylyl-p-phenylenediamine, N, N'-dixylyl-p-phenylenediamine, bis(tributyltin) =Oxido, toxaphene, mirex, hexachlorobuta-1,3-diene, or dicofol to be imported are for testing and research purposes.
  (2) A person who intends to import, by vessel, tunas (excluding albacore or longfinned tunas, bluefin tunas, southern bluefin tunas, and bigeye tuna, and limited to those that are fresh, chilled or frozen) or marlin (excluding swordfish, and limited to those that are fresh, chilled or frozen) (excluding persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry) shall make confirmation with the Minister of Economy, Trade and Industry as prescribed separately.
  (3) A person who intends to import frozen bluefin tunas, southern bluefin tunas, bigeye tuna or swordfish (excluding persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry) shall obtain confirmation from the Minister of Economy, Trade and Industry as prescribed separately.
  (4) A person who intends to import mero (excluding persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry) shall obtain confirmation from the Minister of Economy, Trade and Industry as prescribed separately.
  (5) A person who intends to import whale and preparation thereof (excluding persons who are required to obtain import approval from the Minister of Economy, Trade and Industry under Article 4, paragraph 1 of the Order) shall obtain confirmation from the Minister of Economy, Trade and Industry that said whale or preparation thereof to be imported originate in or are shipped from the countries listed in 9(1).
  (6) A person who intends to import animals or plants originating in the countries listed in column 2 of row 1 of the table below or animals or plants shipped from the countries listed in column 2 of row 2 of the same table, which belong to the species listed in column 3 corresponding to the rows pertaining to said countries listed in column 2 (excluding those listed in the row "Countries or regions other than Countries Listed in III-9(1)" in table 1 under II and all species belonging to Rhincodon, Cetorhinus, Carcharodon, and Hippocampus), as well as parts and Derivatives thereof (in the case of parts and Derivatives of plants belonging to the species listed in CITES Appendix II, limited to those identified based on Appendix II; in the case of parts and Derivatives of animals and plants belonging to the species listed in CITES Appendix III, limited to those identified based on Appendix III), all of which are listed in column 4 corresponding to the rows pertaining to said countries listed in column 2 (excluding those for which Item 2 Approval should be obtained based on the provisions in table 2 under II and those for which confirmation should be obtained from the Minister of Economy, Trade and Industry based on the provisions in 7(7) and (8)) shall, obtain confirmation from the Minister of Economy, Trade and Industry as prescribed separately.
||Country|Species|Goods|
|I|Argentina|Maned wolf|Animals and their parts and derivatives|
|||Pampas cat||
|||Puma (excluding Florida pumas, Costa Rican pumas, and Eastern pumas)||
|||Kodkod||
|||Jaguarundi (excluding North and Central America populations)||
|||||
|||Yellow anaconda||
|||Species listed in CITES Appendix II (with respect to those belonging to Felidae, however, pampas cats, pumas, kodkods, and jaguarondis are excluded)|Furskins (only those originated in Argentina)|
||Australia|Species listed in CITES Appendix II (animals only)|Animals and their eggs|
||Bolivia|Species listed in CITES Appendix II (animals only)|Animals and their parts and derivatives|
||Botswana|African elephant Animals and their parts and derivatives||
||Brazil|Species listed in CITES Appendix II (animals only)|Animals and their parts and derivatives|
||Chile|Culpeo|Animals and their parts and derivatives|
|||Puma (excluding Florida pumas, Costa Rican pumas, and Eastern pumas)||
|||Kodkod||
|||Pampas cat||
||Ecuador|Species listed in CITES Appendix II|Animals and plants, and their parts and derivatives|
||Guatemala|Species listed in CITES Appendix II (animals only), and species listed by the Guatemalan government in CITES Appendix III (animals only)|Animals and their parts and derivatives|
||Honduras|Giant anteater|Animals and their parts and derivatives|
|||Mexican hairy dwarf porcupine||
|||White-nosed coati||
|||Kinkajou||
|||Patagonian hog-nosed skunk||
|||Tayra||
|||Puma (excluding Florida pumas, Costa Rican pumas, and Eastern pumas)||
|||Muscovy duck||
|||Black-bellied whistling duck||
|||King vulture||
|||Red-tailed hawk||
|||Ornate hawk-eagle||
|||American kestrel||
|||Great curassow||
|||Crested guan||
|||Spectacled owl||
|||Barn owl||
|||Cinnamon hummingbird||
||India|Species listed in CITES Appendix II (only those belonging to Ophidia) and species listed by the Indian government in CITES Appendix III (only those belonging to Ophidia)|Hides and skins (only those originated in India)|
||Indonesia|Species listed in CITES Appendix II (animals only)|Hides and skins (only those originated in Indonesia)|
||Malaysia|Cynomolgus monkey|Animals and their parts and derivatives|
|||Pig-tailed macaque||
|||Species listed in CITES Appendix II (only those belonging to Anthozoa or Hydrozoa)|Animals and their parts and derivatives (only those originated in Sabah Province, Malaysia)|
||Namibia|African elephant|Animals and their parts and derivatives|
||Pakistan|Species listed in CITES Appendix II (only those belonging to Mammalia or Class Reptilia)|Animals and their parts and derivatives|
||Paraguay|Species listed in CITES Appendix II|Animals and plants, and their parts and derivatives|
||Peru|Species listed in CITES Appendix II (with respect to those belonging to Mammalia, Class Aves, Class Reptilia, or Class Amphibia, however, red-masked parakeets, scarlet-fronted parakeets, Pacific parrotlets, mountain parakeets, Andean parakeets, and grey-cheeked parakeets are excluded)|Animals and their parts and derivatives|
||South Africa|African elephant|Animals and their parts and derivatives|
||Tanzania|Black-masked lovebird|Animals and their parts and derivatives|
||Democratic Republic of the Congo|Grey parrot (excluding principe parakeets)|Animals|
||Zimbabwe|African elephant|Animals and their parts and derivatives|
|II|Argentina|Species listed in CITES Appendix II (only those belonging to Psittaciformes)|Animals|
||Chad|Species listed in CITES Appendix II|Animals and plants, and their parts and derivatives|
  (7) A person who intends to import live animals belonging to the species listed in CITES Appendix II (excluding those listed in the row "Countries or regions other than Countries Listed in III-9(1)" in table 1 under II and all species belonging to Rhincodon, Cetorhinus, Carcharodon, and Hippocampus) and live animals belonging to the species listed in CITES Appendix III (limited to animals originating in the countries that list them in Appendix III), other than those for which Item 2 Approval should be obtained based on the provisions in table 2 under II and those for which prior confirmation should be obtained based on the provisions in 7(8) shall obtain confirmation from the Minister of Economy, Trade and Industry as prescribed separately.
  (8) A person who intends to import animals and plants, etc. belonging to National Endangered Species of Wild Fauna and Flora listed in table 2 of appended table 1 of the Order for Enforcement of the Act on Conservation of Endangered Species of Wild Fauna and Flora (Cabinet Order No. 17 of 1993; hereinafter referred to as the "Order for Enforcement of the Species Conservation Act") (excluding Specified National Endangered Species of Wild Fauna listed in appended table 3 of the Order for Enforcement of the Species Conservation Act), other than those for which Item 2 Approval should be obtained based on the provisions of table 2 under II and those listed in 8(4)(b) shall obtain confirmation from the Minister of Economy, Trade and Industry as prescribed separately.
  (9) A person who intends to import Class III Psychotropics prescribed in Article 50-9, paragraph 5 of the Narcotics and Psychotropics Control Act (Act No. 14 of 1953; hereinafter referred to as the "Narcotics Control Act") and falls under any of the following cases or a person who intends to import Class II Psychotropics prescribed in Article 50-9, paragraph 4 of the Narcotics Control Act shall obtain confirmation from the Minister of Economy, Trade and Industry as prescribed separately.
    (a) Where such person is a Founder of Psychotropics Testing and Research Institute prescribed in Article 2, item 34 of the Narcotics Control Act, and intends to import psychotropics prescribed in item 6 of the same Article for purposes of academic research or experimental purposes.
    (b) Where such person is a Psychotropics Exporter prescribed in Article 2, item 29 of the Narcotics Control Act (hereinafter referred to as "Psychotropics Exporter"), and intends to imports psychotropics that the person him/herself has exported.
    (c) Where such person is a Psychotropics Exporter, Psychotropics Manufacturer prescribed in Article 2, item 30 of the Narcotics Control Act or Psychotropics User prescribed in item 31 of the same Article and intends to import psychotropics for quality testing.
  (d) Where such person intends to import psychotropics as product samples.
  (10) A person who intends to import substances listed in Annex A of the Montreal Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry), substances listed in Annex B of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry), substances listed in Annex C of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry), and substances listed in Annex E of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry) which are used as raw materials in the manufacturing process of other substances shall obtain confirmation from the Minister of Economy, Trade and Industry that said substances are used as raw materials in the manufacturing process of other substances.
  (11) A person who intends to import substances included in Group I of Annex A of the Montreal Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry) and substances listed in Annex B of the same Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry) which are used for testing and research or analysis shall obtain confirmation from the Minister of Economy, Trade and Industry that said substances are used for testing and research or analysis.
  (12) A person who intends to import substances listed in Annex E of the Montreal Protocol (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry) which are used for quarantine upon import and export of goods shall obtain confirmation from the Minister of Economy, Trade and Industry that said substances are used for quarantine upon import and export of goods.
8. Where a person imports goods listed in (1) to (2) below shall, before obtaining permission under Article 67 of the Customs Act (Act No. 61 of 1954) (approval under Article 73, paragraph 1 of the same Act in the case where such person intends to accept goods before obtaining permission for import; approval under Article 43-3, paragraph 1 of the same Act (including the cases where it is applied pursuant to Article 62 of the same Act) in the case where such person intends to place goods in bonded storehouses or bonded factories), submit the documents listed in (1) to (12) to Customs.
  (1) With respect to poppy seeds and hemp seeds, a document certifying that heat treatment, etc. has been implemented to avoid germination (limited to those issued by the Narcotics Control Department of the Regional Bureau of Health and Welfare, Narcotics Control Department of the Regional Branch of Health and Welfare or Regional Narcotics Control Office which has jurisdiction over the port of discharge concerned)
  (2) With respect to animals belonging to the species listed in CITES Appendix II which originate in or are shipped from countries or regions other than the countries and regions listed in 9(3)(a) and (b) (excluding those listed in the row "Countries or regions other than Countries Listed in III-9(1)" in table 1 under II and all species belonging to Rhincodon, Cetorhinus, Carcharodon, and Hippocampus) and plants belonging to the species listed in the same Appendix which originate in or are shipped from said countries or regions, as well as parts and Derivatives thereof (in the case of parts and Derivatives of plants, limited to those identified based on Appendix II), for all of which Item 2 Approval based on the provisions in table 2 under II or confirmation by the Minister of Economy, Trade and Industry based on the provisions in 7(6) to (8) is not required to be obtained, the original of an export license or re-export certification pertaining to said goods issued by the control authority of the country or region of shipment or other authority similar thereto (hereinafter referred to as the "Control Authority, etc.") in accordance with CITES
  (3) With respect to animals and plants belonging to the species listed in CITES Annex III and parts and Derivatives thereof identified based on Annex III (excluding goods for which Item 2 Approval should be obtained based on the provisions in table 2 under II and goods for which confirmation should be obtained from the Minister of Economy, Trade and Industry based on the provisions in 7(6) to (8)), the documents listed in the lower [right] column in the table below for the respective places of origin listed in the upper [left] column and respective places of shipments listed in the middle column regarding said animals or plants
|Place of origin of the animal or plant|Place of shipment|Document to be submitted|
|Country that lists the animal or plant in Appendix III|Country in which the animal or plant originates|Original of an export license issued by the Control Authority, etc. under CITES|
||Country or region listed in 9(3)(a) or (b) (excluding the country or region in which the animal or plant originates)|Original of a re-export certificate or a document certifying that the goods are processed in the place of shipment (hereinafter referred to as a "processing certificate") (limited to those issued by the Control Authority, etc. under CITES)||
|Country or region other than the countries that list the animal or plant in Appendix III|Country or region listed in 9(3)(a) or (b)|Original of a re-export certificate or processing certificate issued by the Control Authority, etc. under CITES, or of a certificate of origin issued by a public authority of the country or region in which the animal or plant originates|
||Country or region other than the countries listedin 9(3)(a) and (b)|Original of a certificate of origin issued by a public authority of the country or region in which the animal or plant originates|
  (4) (a) With respect to animals and plants belonging to Endangered Species of Wild Fauna prescribed in Article 4, paragraph 2 of the Act on Conservation of Endangered Species of Wild Fauna and Flora (Act No. 75 of 1992) (excluding Specified National Endangered Species of Wild Fauna prescribed in paragraph 5 of the same Article) and their organs and processed products thereof prescribed in Article 6, paragraph 2, item 3 of the same Act (excluding the goods for which Item 2 Approval should be obtained based on the provisions in table 2 under I and table 2 under II, goods prescribed in (2) and (b) or goods for which confirmation should be obtained from the Minister of Economy, Trade and Industry based on the provisions in 7(6) to (8); hereinafter referred to as "Animals/Plants, etc."), a certificate issued by a government organ of the exporting country to the effect that the export of said Animals/Plants, etc. has been permitted (in the case where the exporting country does not require permission to be obtained for the export of said Animals/Plants, etc., a certificate issued by a government organ of the exporting country to the effect that said Animals/Plants, etc. have been legally caught, collected or bred)
    (b) With respect to Animals/Plants, etc. belonging to the species listed in table 1 of appended table 1 and table 1 of appended table 2 of the Order for Enforcement of the Species Conservation Act (excluding the goods for which an import quota should be obtained based on the provisions in table 2 under I and goods for which confirmation should be obtained from the Minister of Economy, Trade and Industry based on the provisions in 7(6) and (7)) which are imported from the United States, Russia or Australia, a certificate issued by a government organ of the exporting country to the effect that export of said Animals/Plants, etc. has been permitted for purposes of academic research or breeding
(5) With respect to radioisotopes prescribed in Article 2, paragraph 2 of the Act on Prevention of Radiation Hazards due to Radioisotopes, etc. (Act No. 167 of 1957; hereinafter referred to as the "Act on Prevention of Radiation Hazards"), the following documents
  (a) In the case of the person who has obtained permission to use radioisotopes, a copy of the license prescribed in Article 9 of the Act on Prevention of Radiation Hazards
  (b) In the case of the person who has made a notification of the use of radioisotopes or notification of the engagement in the sale or lease of radioisotopes, a certificate stating that such person has made notification
(6) With respect to Class III Psychotropics prescribed in Article 50-9, paragraph 5 of the Narcotics Control Act (excluding those for which confirmation should be obtained from the Minister of Economy, Trade and Industry based on the provisions in 7(9)), a copy of the license prescribed in Article 4 of the Narcotics Control Act as applied mutatis mutandis pursuant to Article 50-4 of the Narcotics Control Act
  (7) (a) With respect to N-acetylanthranilic acid and its salts), isosafrole, ergotamine and its salts, ergometrine and its salts, potassium permanganate, safrole, piperonal, acetic anhydride, 3,4-methylenedioxyphenyl-2-propanone, lysergic acid and its salts, and substances containing these (excluding those for which notification should be made under Article 50-31 or Article 50-36 of the Narcotics Control Act), a document certifying that notification has been made under Article 50-29 of the Narcotics Control Act (limited to the cases where Importers of Materials for Narcotics, etc. prescribed in Article 2, item 37 of the Narcotics Control Act (hereinafter referred to as "Importers of Materials for Narcotics, etc.") intend to import said substances) or a document certifying that notification has been made under Article 50-31 of the Narcotics Control Act (limited to the cases where persons other than Importers of Materials for Narcotics, etc. intend to import said substances)
  (b) With respect to acetone, anthranilic acid and its salts, ethyl ether, hydrochloric acid, toluene, piperidine and its salts, methyl ethyl ketone, sulphuric acid, and substances containing these (excluding those for which notification should be made under Article 50-31 or Article 50-36 of the Narcotics Control Act), a document certifying that notification has been made under Article 50-27 of the Narcotics Control Act (limited to the cases where Importers of Materials for Narcotics, etc. intend to import said substances) or a document certifying that notification has been made under Article 50-31 of the Narcotics Control Act (limited to the cases where persons other than Importers of Materials for Narcotics, etc. intend to import said substances)
(8) In the case of import of phenylacetic acid and its salts and substances containing these (excluding those that contain phenylacetic acid at not more than 10%), a copy of the Designation Certificate of Importer of Materials for Stimulants prescribed in Article 5 as applied mutatis mutandis pursuant to Article 30-5 of the Stimulants Control Act (Act No. 252 of 1951)
(9) With respect to fresh or chilled bluefin tunas, southern bluefin tunas or swordfish (excluding those imported by persons who are required to obtain Item 2 Approval from the Minister of Economy, Trade and Industry), a Bluefin Tuna Statistical Document or Bluefin Tuna Re-Export Certificate, Southern Bluefin Tuna Statistical Document or Southern Bluefin Tuna Re-Export Certificate, or Swordfish Statistical Document or Swordfish Re-Export Certificate, respectively
(10) With respect to diamonds (limited to those that fall into the scope of goods listed in Class 71, No. 7102.10, No. 7102.21 and No. 7102.31 in the appended table of the Customs Tariff Act and are enclosed in the container or package without any trace of the container or package having been opened; excluding those originating in or shipped from Liberia or Cote d'Ivoire), a Kimberley Process Certificate issued under the International Certification Scheme for Rough Diamonds adopted at Interlaken on November 5, 2002 in the country or region from which said diamonds are shipped (which means a document certifying that the diamonds pertaining to the certificate have been treated under said scheme)
(11) With respect to Agricultural Chemicals prescribed in the Agricultural Chemicals Control Act (Act No. 82 of 1948) (excluding those that fall under the proviso of paragraph 1 of Article 2 of the same Act), a document certifying that registration has been made under Article 2, paragraph 1 of the same Act
(12) With respect to Pharmaceutical Products prescribed in Article 2, paragraph 1 of the Pharmaceutical Affairs Act (Act No. 145 of 1960) (limited to those containing chemicals listed in Annex A or Annex B of the Stockholm Convention on Persistent Organic Pollutants) and Quasi-Pharmaceutical Products prescribed in paragraph 2 of the same Article (limited to those containing chemicals listed in Annex A or Annex B of the Stockholm Convention on Persistent Organic Pollutants), a copy of a document certifying that a license has been granted under Article 12, paragraph 1 or Article 13, paragraph 1 of the same Act or a written notification made under Article 94, paragraph 1 or Article 95, paragraph 1 of the Ordinance for Enforcement of the Pharmaceutical Affairs Act (Ordinance of the Ministry of Health and Welfare No. 1 of 1961)
9 (1) With regard to the following countries, Item 2 Approval shall not be required for whales and their preparations listed in table 1 under II.
  Antigua and Barbuda, Argentina, Australia, Austria, Chile, Costa Rica, Denmark, Dominica, Finland, France (including French Guyana), Germany, Grenada, India, Ireland, Kenya, Mexico, Monaco, Netherlands, New Zealand, China (including Hong Kong and Macao) Oman, Saint Lucia, Saint Vincent and the Grenadines, Senegal, Solomon Islands, Saint Kitts, South Africa, Sweden, Switzerland, United Kingdom of Great Britain and Northern Ireland, United States of America, Venezuela (Bolivarian Republic of)
(2) With regard to the following countries and regions, Item 2 Approval shall not be required for bluefin tunas (limited to fresh or chilled ones that are bred in the Atlantic Ocean or Mediterranean Sea) listed in table 1 under II.
    Algeria, Angola, Austria, Barbados, Belgium, Bermuda Islands, Brazil, Belize, Canada, Cape Verde, China (including Hong Kong and Macao), Cote d'Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Equatorial Guinea, Estonia, Finland, France, Gabon, Germany, Ghana, Greece, Guatemala, Guinea, Guyana, Honduras, Hungary, Iceland, Ireland, Italy, Republic of Korea, Latvia, Libyan Arab Jamahiriya, Lithuania, Luxembourg, Malta, Mexico, Morocco, Namibia, Netherlands, Antilles, Nicaragua, Norway, Panama, Philippines, Poland, Portugal, Russian Federation, Saint Pierre and Miquelon, Sao Tome and Principe, Senegal, Slovakia, Slovenia, South Africa, Spain, Sweden, Taiwan, Trinidad and Tobago, Tunisia, Turkey, United Kingdom of Great Britain and Northern Ireland, United States of America, Uruguay, Vanuatu, Venezuela (Bolivarian Republic of)
(3) With respect to animals and plants belonging to the species listed in CITES Appendix II and Appendix III which are listed in table 2 under II, as well as their parts and Derivatives, the due date for application for Item 2 Approval, the authority to which a written application should be submitted, the documents to be attached to the application and other necessary matters shall be specified separately; with regard to the countries and regions listed in (a) and (b) below, said approval shall not be required.
  (a) Afghanistan, Albania, Algeria, Antigua and Barbuda, Argentina, Australia, Austria, Azerbaijan, Bahamas, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Chile, China (including Hong Kong and Macao), Colombia, Comoros, Congo, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kuwait, Lao People's Democratic Republic, Latvia, Lesotho, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Macedonia (the former Yugoslav Republic of Macedonia), Madagascar, Malawi, Malaysia, Mali, Malta, Mauritania, Mauritius, Mexico, Monaco, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Norway, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia and Montenegro, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Thailand, Togo, Trinidad and Tobago, Tunisia, Turkey, Uganda, Ukraine, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia, Zimbabwe
  (b) Angola, Bahrain, Cook Islands, North Korea, Haiti, Kiribati, Lebanon, Marshall Islands, Micronesia (Federated States of), Niue, Oman, Solomon Islands, Taiwan, Tonga, Turkmenistan, Turks and Caicos Islands, Tuvalu
(4) With regard to the countries and regions listed in (a) to (e) below, Item 2 Approval shall not be required for substances listed in Annex A of the Montreal Protocol and products listed in Annex D of the same Protocol, substances listed in Annex B of the same Protocol, substances included in Group II of Annex C of the same Protocol and substances listed in Annex E of the same Protocol, substances included in Group III of Annex C of the same Protocol, and substances included in Group I of Annex C of the same Protocol, all of which are listed in table 2 under II.
  (a) Countries and regions regarding which Item 2 Approval II shall not be required for the substances listed in Annex A of the Montreal Protocol and the products listed in Annex D of the same Protocol
    Afghanistan, Albania, Angola, Algeria, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Chile, China (including Hong Kong and Macao), Colombia, Comoros, Congo, Democratic Republic of the Congo, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Republic of Korea, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of), Republic of Moldova, Monaco, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Sao Tome and Principe, Samoa, Saudi Arabia, Senegal, Serbia and Montenegro, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tajikistan, United Republic of Tanzania, Thailand, Macedonia (the former Yugoslav Republic of Macedonia), Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia, Zimbabwe
(b) Countries and regions regarding which Item 2 Approval shall not be required for the substances listed in Annex B of the Montreal Protocol
    Afghanistan, Albania, Algeria, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cameroon, Canada, Cape Verde, Chad, Chile, China (including Hong Kong and Macao), Colombia, Comoros, Congo, Democratic Republic of the Congo, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Ireland, Israel, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Republic of Korea, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of), Republic of Moldova, Monaco, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Sao Tome and Principe, Samoa, Saudi Arabia, Senegal, Serbia and Montenegro, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tajikistan, United Republic of Tanzania, Thailand, Macedonia (the former Yugoslav Republic of Macedonia), Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia, Zimbabwe
  (c) Countries and regions regarding which Item 2 Approval shall not be required for the substances belonging to Group II of Annex C of the Montreal Protocol and the substances listed in Annex E of the same Protocol
    Afghanistan, Albania, Algeria, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cameroon, Canada, Cape Verde, Chad, Chile, China (including Hong Kong and Macao), Colombia, Comoros, Congo, Democratic Republic of the Congo, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Fiji, Finland, France, Gabon, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Ireland, Israel, Italy, Jamaica, Jordan, Kenya, Kiribati, Republic of Korea, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of), Republic of Moldova, Monaco, Mongolia, Morocco, Mozambique, Namibia, Nauru, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, North Korea, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Sao Tome and Principe, Samoa, Saudi Arabia, Senegal, Serbia and Montenegro, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, United Republic of Tanzania, Thailand, Macedonia (the former Yugoslav Republic of Macedonia), Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zimbabwe
  (d) Countries and regions regarding which Item 2 Approval shall not be required for the substances belonging to Group III of Annex C of the Montreal Protocol
    Afghanistan, Albania, Argentina, Australia, Austria, Bahamas, Barbados, Belgium, Bhutan, Brazil, Bulgaria, Burkina Faso, Burundi, Canada, Chile, Comoros, Congo, Democratic Republic of the Congo, Cook Islands, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominica, Eritrea, Estonia, Finland, France, Gabon, Germany, Ghana, Greece, Grenada, Guatemala, Guinea-Bissau, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Jamaica, Jordan, Kiribati, Republic of Korea, Lao People's Democratic Republic, Latvia, Liberia, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritius, Micronesia (Federated States of), Monaco, Nauru, Netherlands, New Zealand, Niger, Nigeria, Niue, North Korea, Norway, Oman, Pakistan, Palau, Panama, Paraguay, Philippines, Poland, Portugal, Romania, Russian Federation, Rwanda, Saint Lucia, Sao Tome and Principe, Samoa, Senegal, Serbia and Montenegro, Seychelles, Sierra Leone, Slovakia, Slovenia, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Taiwan, United Republic of Tanzania, Macedonia (the former Yugoslav Republic of Macedonia), Togo, Tonga, Trinidad and Tobago, Turkey, Tuvalu, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Uruguay, Viet Nam
  (e) Countries and regions regarding which Item 2 Approval shall not be required for the substances belonging to Group I of Annex C of the Montreal Protocol
    Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central African Republic, Chad, Chile, China (including Hong Kong and Macao), Colombia, Comoros, Congo, Democratic Republic of the Congo, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Ireland, Israel, Indonesia, Iran (Islamic Republic of), Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, Republic of Korea, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Republic of Moldova, Micronesia (Federated States of), Monaco, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Sao Tome and Principe, Samoa, Saudi Arabia, Senegal, Serbia and Montenegro, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, United Republic of Tanzania, Thailand, Macedonia (the former Yugoslav Republic of Macedonia), Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United States of America, Uruguay, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia, Zimbabwe
(5) With regard to the following countries and regions, Item 2 Approval shall not be required for Class 1 Designated Chemicals prescribed in Article 2, paragraph 5 of the Chemical Weapons Prohibition Act and chemicals containing Class 1 Designated Chemicals, which are listed in table 2 under II.
  Afghanistan, Albania, Algeria, Andorra, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Chad, Chile, China (including Hong Kong and Macao), Colombia, Comoros, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea , Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guyana, Haiti, State of the City of Vatican, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Ireland, Italy, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lesotho, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of), Monaco, Mongolia, Morocco, Mozambique, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia and Montenegro, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Tajikistan, Thailand, Macedonia (the former Yugoslav Republic of Macedonia), Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia, Zimbabwe
(6) With regard to the following countries and regions, Item 2 Approval shall not be required for southern bluefin tunas (limited to those fresh or chilled) listed in table 1 under II.
  Australia, New Zealand, Philippines, Republic of Korea, Taiwan